Home›Compare›DudeMeds vs Ozari Health

DudeMeds vs Ozari Health: Which Is Better?

Head-to-head comparison of DudeMeds and Ozari Health based on our independent scoring across trust, value, experience, product range, and reputation — plus real pricing for the treatments they both offer.

Our Verdict

Ozari Health scores higher overall in our independent evaluation (62.7/100 vs 59.7/100), leading on value, experience. DudeMeds comes out ahead on product range, reputation. DudeMeds has the lower entry price (from $39/mo vs $99/mo), so the better value depends on which treatment you need.

60

DudeMeds is a Florida-based men's telehealth platform built around low-cost all-inclusive TRT that has expanded into GLP-1s, ED, hair loss, NAD+ and women's HRT.

Visit DudeMeds

Ozari Health is a New York-based GLP-1 telehealth startup, launched in May 2026, that sells compounded semaglutide and tirzepatide at some of the lowest published term-based prices in the category.

Visit Ozari Health

Score Breakdown

DimensionDudeMedsOzari Health
Overall Score59.7/10062.7/100 ✓
Trust & Safety30%55/10055/100
Value25%70/10084/100 ✓
Experience20%45/10060/100 ✓
Product Range15%78/100 ✓60/100
Reputation10%50/100 ✓42/100

At a Glance

Founded20212026
HeadquartersFloridaNew York, NY
Publicly tradedNoNo
Treatment categories72
Treatments listed56
Starting price$39/mo$99/mo

Pricing Where They Compete

Prices shown are based on our most recent research and may not reflect current pricing. Telehealth providers update their pricing frequently. Always verify pricing directly with the provider before purchasing.

CategoryDudeMedsOzari Health
Weight Loss / GLP-1$175–$199
Compounded Semaglutide
$99–$175
Compounded Semaglutide (injectable)
Longevity & Peptides—$100
Glutathione Injection

DudeMeds

+All-inclusive TRT from $77/month bundles testosterone, estrogen blocker, supplies, labs and televisits, among the lowest headline TRT prices in telehealth
+Broad catalog under one account: TRT and enclomiphene, compounded and branded GLP-1s, ED, hair loss, NAD+ and LDN
+No separate membership or doctor fee on GLP-1 plans, with free shipping (per third-party pricing checks)
−Trustpilot 2.3/5 (11 reviews) with reports of unauthorized multi-month renewal charges and no company replies to negative reviews
−Patients report the member portal has been non-functional for months, plus refill delays and lost lab work
−GLP-1 pricing not published; third-party audit found the advertised $149/month entry price unavailable at checkout
Read the full DudeMeds review →

Ozari Health

+Low published term pricing: semaglutide $99/mo and tirzepatide $140/mo on annual prepay, with a first-time 3-month starter at $86/mo and $125/mo
+All five billing tiers (monthly, starter, quarterly, semi-annual, annual) are shown on the product pages before intake, at the same price for every dose
+Names its prescribing physician groups (Arora Health; Wasef Health, PC) and medical directors
−Launched in May 2026; only 15 Trustpilot reviews, all 4–5 stars
−Homepage testimonials dated June 2026 describe 5–6 months on treatment, which a May 2026 launch cannot support
−Cancelling an annual or semi-annual plan early re-prices the months already used at the $175–235 monthly rate
Read the full Ozari Health review →

DudeMeds vs Ozari Health — FAQ

Is DudeMeds better than Ozari Health?

▾

Ozari Health scores higher overall in our independent evaluation (62.7/100 vs 59.7/100), leading on value, experience. DudeMeds comes out ahead on product range, reputation. DudeMeds has the lower entry price (from $39/mo vs $99/mo), so the better value depends on which treatment you need.

Is DudeMeds or Ozari Health cheaper?

▾

DudeMeds has the lower starting price (from $39/mo vs $99/mo for Ozari Health). Starting prices are for the cheapest treatment each offers — compare the specific treatment you need, and check what each price includes.

What do DudeMeds and Ozari Health both offer?

▾

Both platforms treat Weight Loss / GLP-1, Longevity & Peptides. DudeMeds covers 7 treatment categories total and Ozari Health covers 2.

Still deciding?